sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
FDMT
Updated 10/6/2026, 4:41 PM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics, Inc. | Sale | $22,318 | Bizily Scott Chief Legal Officer | 1,635 sh | at $13.65 | Filed Sep 22, 6:43 PM ET | Filing | |
| FDMT 4D Molecular Therapeutics, Inc. | Sale | $811,004 | Kirn David See Remarks, Director | 58,333 sh | at $13.90 | Filed Sep 16, 5:13 PM ET | Filing | |
| FDMT 4D Molecular Therapeutics, Inc. | Sale | $8,176 | Bizily Scott Chief Legal Officer | 584 sh | at $14.00 | Filed Sep 3, 6:55 PM ET | Filing | |
| FDMT 4D Molecular Therapeutics, Inc. | Sale | $1,088,273 | Kirn David See Remarks, Director | 69,076 sh | at $15.75 | Filed Aug 21, 4:06 PM ET | Filing | |
| FDMT 4D Molecular Therapeutics, Inc. | Sale | $39,567 | Bizily Scott Chief Legal Officer | 3,270 sh | at $12.10 | Filed Aug 17, 5:34 PM ET | Filing | |
| FDMT 4D Molecular Therapeutics, Inc. | Sale | $274,596 | Kirn David See Remarks, Director | 26,842 sh | at $10.23 | Filed Aug 5, 4:10 PM ET | Filing | |
| FDMT 4D Molecular Therapeutics, Inc. | Sale | $124,722 | Kirn David See Remarks, Director | 12,415 sh | at $10.05 | Filed Aug 4, 4:45 PM ET | Filing | |
| FDMT 4D Molecular Therapeutics, Inc. | Sale | $737,410 | Kirn David See Remarks, Director | 58,333 sh | at $12.64 | Filed Jul 14, 5:04 PM ET | Filing |